Biophytis SA American Depositary Share (0.01 Euro)
BPTS
BPTS was delisted on the 25th of April, 2024.
2 hedge funds and large institutions have $3.97K invested in Biophytis SA American Depositary Share (0.01 Euro) in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
806% more capital invested
Capital invested by funds: $438 → $3.97K (+$3.53K)
0% more funds holding
Funds holding: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GI
GAMMA Investing
Foster City,
California
|
+$8.31K |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$75 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$253 |
BPTS Hedge Fund Activity: Q2 2024 in Review
2 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Biophytis SA American Depositary Share (0.01 Euro) (BPTS) for Q2 2024, worth a combined $3.97K — up 806% from $438 a quarter earlier.
Fund positioning in BPTS was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was GAMMA Investing, opening a new position worth an estimated $8.31K. The largest seller was UBS Group, exiting entirely with an estimated $253 sold.
- 2 institutional investors held Biophytis SA American Depositary Share (0.01 Euro) (BPTS) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $3.97K of Biophytis SA American Depositary Share (0.01 Euro) stock for Q2 2024, up 806% quarter-over-quarter.
- 1 fund opened new Biophytis SA American Depositary Share (0.01 Euro) positions in Q2 2024 and 1 closed out, a net change of 0 holders.
- The largest Biophytis SA American Depositary Share (0.01 Euro) buyer in Q2 2024 was GAMMA Investing, an estimated $8.31K added.
- The largest Biophytis SA American Depositary Share (0.01 Euro) seller in Q2 2024 was UBS Group, an estimated $253 sold.
Based on aggregated 13F filings for Q2 2024.